| 1 |
31209198 | Targeting the cell cycle in head and neck cancer by Chk1 inhibition: a novel concept of bimodal cell death. | 2019 Jun 17 |
1 |
| 2 |
31717700 | Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia. | 2019 Oct 25 |
1 |
| 3 |
27939202 | G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1. | 2017 Feb |
1 |
| 4 |
28698200 | Targeting AXL and mTOR Pathway Overcomes Primary and Acquired Resistance to WEE1 Inhibition in Small-Cell Lung Cancer. | 2017 Oct 15 |
1 |
| 5 |
25283841 | A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations. | 2015 Apr |
2 |
| 6 |
25308916 | Targeting histone deacetylases (HDACs) and Wee1 for treating high-risk neuroblastoma. | 2015 Jan |
1 |
| 7 |
25458954 | Synergistic antitumor interactions between MK-1775 and panobinostat in preclinical models of pancreatic cancer. | 2015 Jan 28 |
2 |
| 8 |
26529495 | Synergistic anti-leukemic interactions between panobinostat and MK-1775 in acute myeloid leukemia ex vivo. | 2015 |
4 |
| 9 |
24179152 | CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo. | 2014 Apr |
1 |
| 10 |
25084614 | CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells. | 2014 Aug 1 |
3 |
| 11 |
25301733 | Pharmacological targeting the ATR-CHK1-WEE1 axis involves balancing cell growth stimulation and apoptosis. | 2014 Nov 15 |
1 |
| 12 |
23148684 | Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition. | 2012 Nov 13 |
1 |